Professors Jeffrey Henderson (right) and Rob Macgregor
Award will support research to advance novel method of modifying cells for testing new gene therapies.
Jeffrey Henderson and Rob Macgregor from the Leslie Dan Faculty of Pharmacy have received one of U of T’s prestigious Connaught Innovation Awards. The award will support their research examining a new low-cost, scale-independent and efficient method to transfect difficult-to-modify cell types such as stem cells. Improving modifications of such cells will enhance testing of new gene and biological therapeutics.
The new biophysical method uses rapid changes in hydrostatic pressure to introduce genes and other materials into difficult-to-modify primary cells, as well as identifying important differences between normal and cancer-causing cells. This method can be used without specialized equipment or consumables, with direct implementation of high safety measures.
Henderson and Macgregor recently published a paper in Scientific Reports describing the method, demonstrating its comparable efficacy introducing genetic material into cells of both experimentally and clinically significance. With the Connaught Innovation Award, the researchers will be developing a real-time dynamic high pressure microscope resource for University of Toronto researchers and conducting further research into advancing this technology for commercialization.
Eighteen researchers at the university received Connaught Innovation Awards, which provide seed funding to advance technologies that have potential to impact society.
More News
Image
U of T pharmacy students earn national recognition at PDW 2026
Nineteen PharmD pharmacy students participated in Professional Development Week (PDW) 2026 in Québec City, earning national and local awards while contributing to advocacy and professional development initiatives.
Read More
Image
U of T and Moderna partner to advance vaccine science, cancer treatment and AI-driven therapeutics
Supported by Moderna Canada, Rick Lu, a postdoctoral researcher in the Li Lab, is using lipid nanoparticles to deliver precise mRNA instructions, advancing safer and more scalable therapies, including cancer treatments.
Read More
Image
Preparing pharmacy students to lead: Zebrina Kassam named 2026 Leader-in-Residence
New Leader-in-Residence to focus on women in leadership through mentorship and networking opportunities
Read More